Induced Pluripotent Stem Cell–Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations

Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain

(2016) Wenrui Huang et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Whole Exome Sequencing and Heterologous Cellular Electrophysiology Studies Elucidate a Novel Loss-of-Function Mutation in the CACNA1A-Encoded Neuronal P/Q-Type Calcium Channel in a Child With Congenital Hypotonia and Developmental Delay

(2016) Derek L. Weyhrauch et al.   PEDIATRIC NEUROLOGY

Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy

(2016) Sinead L. Murphy et al.   Journal of Cardiovascular Translational Research

Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Orα-Tropomyosin Mutation for Hypertrophic Cardiomyopathy

(2016) Marisa Ojala et al.   Stem Cells International

Effect of a myosin regulatory light chain mutation K104E on actin-myosin interactions

(2015) D. Duggal et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells

(2014) Lu Han et al.   CARDIOVASCULAR RESEARCH

Correction

(2014)   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Endothelin‐1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy–Induced Pluripotent Stem Cell–Derived Cardiomyocytes

(2014) Atsushi Tanaka et al.   Journal of the American Heart Association

Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy

(2013) Katarzyna Kazmierczak et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells

(2013) Feng Lan et al.   Cell Stem Cell

Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy

(2012) N. Sun et al.   Science Translational Medicine

Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish

(2011) J. R. Becker et al.   Disease Models & Mechanisms

Cross-bridge kinetics in myofibrils containing familial hypertrophic cardiomyopathy R58Q mutation in the regulatory light chain of myosin

(2011) P. Mettikolla et al.   JOURNAL OF THEORETICAL BIOLOGY

Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice

(2009) Theodore P. Abraham et al.   CARDIOVASCULAR RESEARCH

Dual Variation in SCN5A and CACNB2b Underlies the Development of Cardiac Conduction Disease without Brugada Syndrome

(2009) DAN HU et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Severe Heart Failure and Early Mortality in a Double-Mutation Mouse Model of Familial Hypertrophic Cardiomyopathy

(2008) Tatiana Tsoutsman et al.   CIRCULATION

Regulatory light chain mutations associated with cardiomyopathy affect myosin mechanics and kinetics

(2008) Michael J. Greenberg et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults

(2008) Hiroyuki Morita et al.   NEW ENGLAND JOURNAL OF MEDICINE

Calcium Cycling and Signaling in Cardiac Myocytes

(2007) Donald M. Bers   Annual Review of Physiology